APLS
Apellis Pharmaceuticals Inc.
$23.57
+$0.74(+3.24%)
43
Overall
35
Value
45
Tech
50
Quality
Market Cap
$2.76B
Volume
1.02M
52W Range
$16.10 - $30.60
Target Price
$33.95
EPS Estimates Overview
| Current Quarter | $-0.41 | Next Quarter | $-0.44 |
| Current Year | $0.23 | Next Year | $-1.19 |
| QoQ Growth | -7.3% | YoY Growth | -617.4% |
| 3Y EPS CAGR | +43.4% | Target Price | $33.95 |
| Consensus | Buy | Upside | +44.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $23.57 | +3.2% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW